Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Lieping Chen
Yale University, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
AstraZeneca Pharmaceuticals
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
The required information is included in the attached document
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
The Yale SPORE in Lung Cancer will identify and test novel therapeutic approaches targeting relevant biologic pathways in lung cancer progression. The proposed innovative translational studies of immunotherapeutics, tyrosine kinase inhibitors, microRNA-based therapeutics and smoking cessation interventions combine preclinical research, analysis of patient tumors, and evaluation of clinical trials to guide the selection of therapies most likely to provide benefit to lung cancer patients.
Filed on September 15, 2015.
Tell us what you know about Lieping Chen's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Lieping Chen”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Lieping Chen | Yale University | Conflict of Interest | AstraZeneca Pharmaceuticals | $10,000 - $19,999 |
| Lieping Chen | Yale University | Conflict of Interest | AstraZeneca Pharmaceuticals | $10,000 - $19,999 |
| Lieping Chen | Yale University | Conflict of Interest | Bristol Meyers Squibb, Inc. | $20,000 - $39,999 |
| Lieping Chen | Yale University | Conflict of Interest | Bristol-Myers Squibb, Inc. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.